Back to search
FDAFDA · Food and drugs·Recall number D-1746-2015

Testosterone 25 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN

Published September 23, 2015 · Recall initiated: June 2, 2015

Summary

FDA records drug Class II recall D-1746-2015, published September 23, 2015 and initiated June 2, 2015. Recalling firm: The Compounding Pharmacy of America; Status: Terminated; Reported quantity: 240 pellets; Lot: All lots distributed between November 2014 and May 2015; 12102014@3, 6/8/2015; 12042014@62, 6/2/2015; 01192015@15, 7/18/2015; 01062015@12, 7/5/2015; 02202015@23, 8/19/2015; 02242015@35, 8/23/2015; 03032015@17, 8/30/2015; 03252015@9, 9/21/2015; 04292015@19, 10/26/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Compounding Pharmacy of America
Distributor
Nationwide
Lot
All lots distributed between November 2014 and May 2015; 12102014@3, 6/8/2015; 12042014@62, 6/2/2015; 01192015@15, 7/18/2015; 01062015@12, 7/5/2015; 02202015@23, 8/19/2015; 02242015@35, 8/23/2015; 03032015@17, 8/30/2015; 03252015@9, 9/21/2015; 04292015@19, 10/26/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Testosterone 25 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN recalled?

Yes. FDA published recall D-1746-2015 on September 23, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone